SCHEMBL7708468

SCHEMBL7708468

Cc1ccc(Cc2cnc(N3CCC(C(N)=O)CC3)nc2N2CCN(C)CC2)cc1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.46
TP53 P04637 2/20 0.46
HTR6 P50406 1/20 0.44
POLB P06746 1/20 0.42
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
KMT2A Q03164 5/20 0.41
MEN1 O00255 2/20 0.41
ALDH1A1 P00352 2/20 0.40
TSHR P16473 2/20 0.39
KIT P10721 1/20 0.39
RXFP1 Q9HBX9 1/20 0.38
KDM4E B2RXH2 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
HRH4 Q9H3N8 1/20 0.38
MAPT P10636 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7714521 0.81 SMO (0.46) LMNATP53HTR6POLBSMN1; SMN2
SCHEMBL7714282 0.76 HRH4 (0.56) HTR6HRH4
SCHEMBL7708441 0.76 TSHR (0.57) LMNATP53HTR6SMN1; SMN2KMT2A
SCHEMBL8137500 0.76 KDM4E (0.41) HTR6SMN1; SMN2ALDH1A1TSHRKIT
SCHEMBL7714255 0.74 SMN1; SMN2 (0.53) LMNATP53HTR6POLBSMN1; SMN2
SCHEMBL8132534 0.74 LMNA (0.38) LMNATP53NPC1RAB9ASMN1; SMN2
SCHEMBL7714269 0.74 TSHR (0.49) LMNANPC1RAB9ASMN1; SMN2TSHR
SCHEMBL7714288 0.71 DHFR (0.39)
SCHEMBL7708456 0.69 HRH4 (0.55) HTR6HRH4
SCHEMBL2560186 0.68 RAB9A (0.61) NPC1RAB9ASMN1; SMN2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP claimed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO claimed
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US disclosed